CytoMed Therapeutics (GDTC) Debt Ratio (2021 - 2025)

CytoMed Therapeutics has disclosed Debt Ratio across 5 years of filings, most recently posting 0.06 for Q4 2025.

• In Q4 2025, Debt Ratio rose 20.91% year-over-year to 0.06; the TTM figure through Dec 2025 stood at 0.06 (up 20.91% YoY), while the FY2025 annual figure was 0.02, up 39.34% from the prior year.
• Debt Ratio came in at 0.06 for Q4 2025 at CytoMed Therapeutics, up from 0.0 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.22 in Q4 2022 to a low of 0.0 in Q2 2025.
• Average Debt Ratio over 5 years is 0.07, with a median of 0.04 recorded in 2023.
• Year-over-year, Debt Ratio tumbled 82.34% in 2023 and increased 23.76% in 2024.
• Over 5 years, Debt Ratio stood at 0.22 in 2021, then advanced by 1.08% to 0.22 in 2022, then plunged by 82.34% to 0.04 in 2023, then advanced by 21.3% to 0.05 in 2024, then gained by 20.91% to 0.06 in 2025.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.06 in Q4 2025, 0.0 in Q2 2025, and 0.05 in Q4 2024.